InsidersTradesSigma
Follow the 비씨월드제약 stock price and the full management transaction log of the company, a listed issuer based in South Korea. Shares trade on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 비씨월드제약 has recorded 17 reports. Market capitalisation: €31.4bn. The latest transaction was reported on 7 May 2026 (Other). Among the most active insiders: 홍성한. Every trade is accessible without an account.
17
Insider Decl.
n/a
Thresholds
€26,078
7 ops.
Buy Volume
n/a
1 ops.
Sell Volume
7Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 20,113 of 29,063 companies
38.9
score / 100
Value42
Quality36
FCF yld4.9%
Earn yld-15%
EV/EBITDA11.9x
ROE9.8%
Gross mgn40%
Net mgn-6.5%
Debt/EBITDA8.7x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 7 May 2026
Declarations17 total
17 of 17 declarations
关于 비씨월드제약
BC World Pharma 是一家医疗保健和制药领域的公司，在 XKRX 上市。该公司专注于药品的开发和营销。